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trafficking also modulates neutrophil apoptosis, another control 
point in resolving inflammation. Data emerging from a variety 
of experimental models demonstrated that resolvins and protec-
tins limit adaptive immunity in asthma, attenuate adipose tis-
sue inflammation and metabolic dysfunctions, including type-2 
diabetes mellitus-associated insulin resistance and non-alcoholic 
fatty acid liver disease, and protect the kidney against diabetic 
nephropathy. The glucocorticoid-regulated protein annexin A1 
may act in concert with lipoxins to limit inflammation underly-
ing myocardial ischemia/reperfusion, arthritis, multiple sclerosis, 
and sepsis. Altering local adenosine signaling affects leukocyte 
activation and trafficking, and may restore tissue homeostasis in 
liver injury and rheumatoid arthritis. The nuclear proteins pro-
liferating cell nuclear antigen (PCNA) and myeloid nuclear dif-
ferentiation antigen (MNDA) play opposing roles in modulating 
neutrophil apoptosis in patient with sepsis. Targeting the com-
plement C5a receptors C5Ra and C5L2 may attenuate excessive 
inflammation in sepsis and autoimmune diseases. Intracellular 
molecular mechanisms have also been implicated in dampen-
ing inflammation. The NOD-like receptors NOD1 and NOD2 
recognize intracellular pathogens and activate transcriptional 
responses that would lead to restriction of infection. Suppression 
of IFNγ production in T lymphocytes by allopurinol may attenu-
ate cell-mediated inflammatory diseases.
This Research Topic focuses on articles that discuss the molec-
ular mechanisms governing the function and fate of leukocytes 
during inflammation and identify potential targets for develop-
ment of innovative therapeutic approaches for the treatment of 
inflammatory pathologies based on mimicking and/or activating 
endogenous pro-resolution mechanisms.
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Inflammation is the principal defense mechanism against  invading 
pathogens and host injury. Neutralization and elimination of the 
offending insult ideally prompts resolution of inflammation and 
restoration of tissue homeostasis. Excessive or dysregulated inflam-
matory responses together with impaired repair processes results in 
non-resolving inflammation and persisting tissue damage, which 
is now considered as a critical component of many chronic human 
diseases. Ground-breaking work during the past decade has led 
to the recognition that resolution of inflammation is a tightly 
controlled active process that involves generation of a new class 
of lipid mediators, proteins, and autacoids. These endogenous 
molecules possess overlapping but not fully identical biological 
properties and may act simultaneously or sequentially to regulate 
processes that are essential for timely and complete resolution of 
inflammation. Among these mechanisms are sequestering and sup-
pression of generation of pro-inflammatory cytokines, inhibition 
of inflammatory cell trafficking into inflamed sites, promotion 
of neutrophil apoptosis, and macrophage polarization into M2 
(alternatively activated or pro-resolution) phenotype, and facilita-
tion of removal of apoptotic neutrophils and other cell types via 
efferocytosis and tissue repair.
During the past years much progress has been made in the 
identification and characterization of pro-resolution media-
tors and signaling circuits. Of these, protein mediators, such 
as annexin A1, and novel classes of lipid mediators, including 
arachidonic acid-derived lipoxins, and omega-3 polyunsaturated 
fatty acid-derived resolvins, protectins, and maresins exhibit dual 
anti-inflammatory and pro-resolution properties. Extensive 
research has characterized biosynthetic pathways, G-protein-
coupled receptors, downstream intracellular signaling pathways, 
and identified several microRNAs that are involved in the regu-
lation of pro-resolving molecular and cellular circuits. While 
in inflamed sites neutrophils interact with other cells in their 
immediate vicinity to produce these lipid mediators, eosino-
phil granulocytes can also generate pro-resolving mediators from 
omega-3 polyunsaturated fatty acids, indicating an important 
role for this type of leukocytes in inflammatory resolution. 
Resolvins facilitate macrophage polarization into the M2 phe-
notype. Lipoxins and resolvins interfere with β2 integrin-medi-
ated outside in signaling that in addition to governing leukocyte 
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